Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer

Radiotherapy and Oncology

Volumn 84, Issue 2, 2007, Pages 164-170

  Cozzarini, Cesare ^a   Fiorino, Claudio ^a   Di Muzio, Nadia ^a   Alongi, Filippo ^a   Broggi, Sara ^a   Cattaneo, Mauro ^a   Montorsi, Francesco ^b   Rigatti, Patrizio ^b   Calandrino, Riccardo ^a   Fazio, Ferruccio ^a,c,d  

^a Department of Radiotherapy ^*

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

IMRT; Pelvis irradiation; Prostate cancer; Tomotherapy; Toxicity

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER; CANCER LOCALIZATION; CANCER RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HELICAL TOMOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; PELVIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; PROSTATE SURGERY; PROSTATECTOMY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM; RECTUM HEMORRHAGE;

HUMANS; MALE; PELVIS; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; URINARY BLADDER;

EID: 34548132406     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.07.013     Document Type: Article

References (43)

1. Ashman J.B., Zelefsky M.J., Hunt M.S., Leibel S.A., and Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 765-771
2. Benoit R.M., Naslund M.J., and Cohen J.K. Complications after radical retropubic prostatectomy in the medicare population. Urology 56 (2000) 116-120
3. Brenner D.J. Hypofractionation for prostate cancer radiotherapy - what are the issues?. Int J Radiat Oncol Biol Phys 57 (2003) 912-914
4. Brenner D.J. Toward optimal external-beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 315-316
5. Cavey M.L., Bayouth J.E., Colman M., Endres E.J., and Sanguineti G. IMRT to escalate the dose to the prostate while treating the pelvic nodes. Strahlenther Onkol 181 (2005) 431-441
6. Cozzarini C., Fiorino C., Ceresoli G.L., et al. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy). Int J Radiat Oncol Biol Phys 55 (2003) 688-694
7. Cozzarini C., Bolognesi A., Ceresoli G.L., et al. Role of postoperative radiotherapy after pelvic lymphadenectomy and radical retropubic prostatectomy: a single institute experience of 415 patients. Int J Radiat Oncol Biol Phys 59 (2004) 674-683
8. Dirix P., Haustermans K., Junius S., Withers R., Oyen R., and Van Poppel H. The role of whole pelvic radiotherapy in locally advanced prostate cancer. Radiother Oncol 79 (2006) 1-14
9. Fiorino C., Cozzarini C., Vavassori V., et al. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. Radiother Oncol 64 (2002) 1-12
10. Fiorino C., Dell'Oca I., Pierelli A., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 78 (2006) 276-282
11. Fiorino C., Sanguineti G., Cozzarini C., et al. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57 (2003) 953-962
12. Fokdal L., Honore H., Hoyer M., and von der M. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy. Radiother Oncol 74 (2005) 203-210
13. Fowler J.F., Ritter M.A., Chappell R.J., and Brenner D.J. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 56 (2003) 1093-1104
14. Grigorov G., Kron T., Wong E., Chen J., Sollazzo J., and Rodrigues G. Optimization of helical tomotherapy treatment plans for prostate cancer. Phys Med Biol 48 (2003) 1933-1943
15. Hu J.C., Gold K.F., Pashos C.L., Mehta S.S., and Litwin M.S. Temporal trends in radical prostatectomy complications from 1991 to 1998. J Urol 169 (2003) 1443-1448
16. Hysing L.B., Kvinnsland Y., Lord H., and Muren L.P. Planning organ at risk volume margins for organ motion of the intestine. Radiother Oncol 80 (2006) 349-354
17. Jani A.B., Su A., and Milano M.T. Intensity-modulated versus conventional pelvic radiotherapy for prostate cancer: analysis of acute toxicity. Urology 67 (2006) 147-151
18. Kvinnsland Y., and Muren L.P. The impact of organ motion on intestine doses and complication probabilities in radiotherapy of bladder cancer. Radiother Oncol 76 (2005) 43-47
19. Letschert J.G., Lebesque J.V., Aleman B.M., et al. The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol 32 (1994) 116-123
20. Low D.A., Harms W.B., Mutic S., and Purdy J.A. A technique for the quantitative evaluation of dose distributions. Med Phys 25 (1998) 656-661
21. Luxton G., Hancock S.L., and Boyer A.L. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 59 (2004) 267-284
22. Mackie T.R., Kapatoes J., Ruchala K., et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 89-105
23. Mackie T.R., Holmes T., Swerdloff S., et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 20 (1993) 1709-1719
24. Marks L.B., Carroll P.R., Dugan T.C., and Anscher M.S. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31 (1995) 1257-1280
25. Martinez-Monge R., Fernandes P.S., Gupta N., and Gahbauer R. Cross-sectional nodal atlas: a tool for the definition of clinical target volumes in three-dimensional radiation therapy planning. Radiology 211 (1999) 815-828
26. Minsky B.D., Conti J.A., Huang Y., and Knopf K. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13 (1995) 1409-1416
27. Mutic S., Malyapa R.S., Grigsby P.W., et al. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55 (2003) 28-35
28. Nutting C.M., Convery D.J., Cosgrove V.P., et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 649-656
29. Nuyttens J.J., Robertson J.M., Yan D., and Martinez A. The position and volume of the small bowel during adjuvant radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 51 (2001) 1271-1280
30. Peeters S.T., Heemsbergen W.D., van Putten W.L., et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61 (2005) 1019-1034
31. Popken G., Sommerkamp H., Schultze-Seemann W., Wetterauer U., and Katzenwadel A. Anastomotic stricture after radical prostatectomy. Incidence, findings and treatment. Eur Urol 33 (1998) 382-386
32. Price R.A.J., Hannoun-Levi J.M., Horwitz E., et al. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 583-592
33. Roach M., DeSilvio M., Lawton C., et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 21 (2003) 1904-1911
34. Roach M., DeSilvio M., Valicenti R., et al. Whole-pelvis, "mini-pelvis", or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys 66 (2006) 647-653
35. Sanguineti G., Cavey M.L., Endres E.J., et al. Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76 Gy?. Strahlenther Onkol 182 (2006) 543-549
36. Sanguineti G., Cavey M.L., Endres E.J., Brandon G.G., and Bayouth J.E. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?. Int J Radiat Oncol Biol Phys 64 (2006) 151-160
37. Shepard D.M., Olivera G.H., Reckwerdt P.J., and Mackie T.R. Iterative approaches to dose optimization in tomotherapy. Phys Med Biol 45 (2000) 69-90
38. Tho L.M., Glegg M., Paterson J., et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 66 (2006) 505-513
39. Thompson I.M.J., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 296 (2006) 2329-2335
40. Vaarkamp J., Adams E.J., Warrington A.P., and Dearnaley D.P. A comparison of forward and inverse planned conformal, multi segment and intensity modulated radiotherapy for the treatment of prostate and pelvic nodes. Radiother Oncol 73 (2004) 65-72
41. Vavassori V., Fiorino C., Rancati T., et al. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 66 (2007) 1401-1410
42. Wang-Chesebro A., Xia P., Coleman J., Akazawa C., and Roach M. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 654-662
43. Wawroschek F., Vogt H., Wengenmair H., et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 70 (2003) 303-310